hsa-mir-(4328, 4422, 548z and -628-5p) in diabetic retinopathy: diagnosis, prediction and linking a new therapeutic target
Conclusionhsa-mir-(4328, 4422, 548z and -628-5p) in whole blood are protective factors for DR as novel biomarkers for diagnosis and prediction. In addition, our research provides new drug directions for the treatment of DR, such as Diosmin, Atorvastatin, and so on.
Source: Acta Diabetologica - Category: Endocrinology Source Type: research
More News: Atorvastatin Calcium | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Genetics | Lipitor | Statin Therapy | Zivast